Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chubb
Cipla
McKesson
Merck
Covington
Dow
Harvard Business School
Moodys

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ALITRETINOIN

« Back to Dashboard

Clinical Trials for Alitretinoin

Trial ID Title Status Sponsor Phase Summary
NCT00002188 A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma Completed Ligand Pharmaceuticals Phase 2 The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002188 A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma Completed Anderson Clinical Research Phase 2 The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002439 A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma Completed Ligand Pharmaceuticals N/A The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
NCT00002439 A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma Completed Anderson Clinical Research N/A The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Alitretinoin

Condition Name

Condition Name for Alitretinoin
Intervention Trials
Hand Dermatoses 3
Eczema 2
HIV Infections 2
Sarcoma, Kaposi 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Alitretinoin
Intervention Trials
Eczema 5
Dermatitis 4
Skin Diseases 3
Hand Dermatoses 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Alitretinoin

Trials by Country

Trials by Country for Alitretinoin
Location Trials
United States 32
Germany 11
Canada 6
Netherlands 3
Denmark 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Alitretinoin
Location Trials
Minnesota 1
Washington 1
Nebraska 1
New Hampshire 1
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Alitretinoin

Clinical Trial Phase

Clinical Trial Phase for Alitretinoin
Clinical Trial Phase Trials
Phase 4 2
Phase 3 8
Phase 2 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Alitretinoin
Clinical Trial Phase Trials
Completed 11
Recruiting 3
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Alitretinoin

Sponsor Name

Sponsor Name for Alitretinoin
Sponsor Trials
Basilea Pharmaceutica 6
University Hospital, Gentofte, Copenhagen 2
University Medical Center Groningen 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Alitretinoin
Sponsor Trials
Other 14
Industry 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Healthtrust
US Department of Justice
Cerilliant
Citi
Teva
Medtronic
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.